DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR FIRST AND SECOND HEALTH GROUPS IN NATIVE-BORN CHILDREN OF FAR NORTH Russian patent published in 2013 - IPC G01N33/48 G01N33/68 

FIELD: medicine.

SUBSTANCE: whole peripheral blood is examined for activity of the enzyme glycerol-3-phosphate dehydrogenase (G3PDG). If the value is 11.42 mcE/l or more, the enzyme activity is considered to be normal, and a child is referred to the first health group, and if the value is below 11.42 mcE/l or, the enzyme activity is considered to be decreased, and a child is referred to the second health group.

EFFECT: use of the declared technique allows combining minimal time consumption and the objective assessment of the children's health status, and if needed, with the well-timed prescription of preventive or therapeutic measures.

2 ex